Sales Performance - The sales price of the main product, soybean protein, fluctuated significantly this year, especially with a noticeable decline in the first half compared to the previous year. The second half has stabilized [2]. - The company will adjust product prices and sales strategies based on market conditions and operational performance to enhance market sales and ensure operational efficiency [2]. Export Business - The export business has faced pressure due to factors such as international conflicts, inflation, and interest rate hikes, leading to decreased purchasing power in some markets [2]. - The company is actively exploring new markets and applications through market maintenance and the development of new products and clients to maintain stable export growth [2]. Shareholder Communication - The company has communicated with shareholders regarding their intentions to reduce holdings following the lifting of stock restrictions, emphasizing the importance of conveying the company's investment value and operational philosophy [3]. - The company will fulfill its disclosure obligations in a timely manner if any shareholders decide to reduce their holdings [3]. Corporate Governance - The independent director confirmed the ability to perform supervisory roles within the board and emphasized adherence to legal and regulatory standards in decision-making processes [3]. - The independent director will advocate for the company to fulfill its profit distribution obligations in accordance with relevant regulations [3]. Financial Outlook - The company is optimistic about achieving better performance in Q4 2023 compared to the previous year, with a focus on prudent market control to enhance operational efficiency [4]. - The increase in export volume is not directly related to the depreciation of the RMB, as the foreign trade business is settled in USD, and the impact of RMB depreciation on overall operations is minimal [4].
嘉华股份(603182) - 嘉华股份投资者关系活动记录表